During the last few years, the cannabis industry has evolved into a global opportunity as several major international markets have legalized cannabis.

From Germany to Colombia, there are several burgeoning international markets that are in the early stages of a major growth cycle and this is a trend that we are bullish on.

Although the global cannabis market has recorded incredible growth, there are only a few companies that are capitalizing on multiple markets. The operators have proven to be able to execute on international expansion initiatives and are typically led by a management team that has taken a strategic approach to growth.

Another common trait with companies that are capitalizing on major international cannabis markets is related to the balance sheet. These operators tend to be well capitalized and have the ability to tap the capital markets when it needs to raise proceeds.

We analyze a variety of factors to better understand the short and long-term opportunity that is associated with international cannabis markets. Some of the most important factors that we research include:

Population demographic
Type of market (medical, recreational, or CBD only)
Regulatory structure (i.e. governing body and number of licenses issues)
Climate
Geographic location as it relates to the import and export market

A Global Expansion to be Aware of

When it comes to the international cannabis opportunity, some of the markets that we are the most excited about include but are not limited to: Germany, Colombia, Australia, Mexico, Spain, and Denmark.

In regards to Colombia and Germany, the countries allow for insurance companies to cover the cost of medical cannabis. Due to this structure, these markets have seen a significant uptick in the number of medical cannabis patients and find this to be an important metric when analyzing each country’s growth prospects.

Over the next year, we expect other countries to rollout a model that is similar to Colombia and Germany and believe that this will be a major catalyst for the global cannabis market. A key reason for this view is related to the data that is being generated in Colombian and German medical cannabis patients. Now, countries can make decisions that are based on data and expect this to play an important role in how the international cannabis markets expands.

If you are interested in learning more about companies that are positioned to capitalize on the global cannabis market, please send an email to support@technical420.com with the subject “International Cannabis Companies” to be added to our distribution list.

For the fastest access to data on companies that are positioned to capitalize on the global cannabis market,, sign up for our free newsletter!

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.